Ovarian ablation as adjuvant therapy for breast cancer

被引：23

作者：

Dees, EC

Davidson, NE

机构：

[1] Johns Hopkins Univ, Sch Med, Johns Hopkins Oncol Ctr, Baltimore, MD 21231 USA

[2] Univ N Carolina, Dept Hematol & Oncol, Chapel Hill, NC USA

来源：

SEMINARS IN ONCOLOGY | 2001年 / 28卷 / 04期

关键词：

D O I：

10.1053/sonc.2001.26143

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：322 / 331

页数：10

共 46 条

[1]

ABE O, 1992, LANCET, V339, P71

[2] Is chemotherapy alone adequate for young women with oestrogen-receptor-positive breast cancer? [J].

Aebi, S ;

Gelber, S ;

Castiglione-Gertsch, M ;

Gelber, RD ;

Collins, J ;

Thürlimann, B ;

Rudenstam, CM ;

Lindtner, J ;

Crivellari, D ;

Cortes-Funes, H ;

Simoncini, E ;

Werner, ID ;

Coates, AS ;

Goldhirsch, A .

LANCET, 2000, 355 (9218) :1869-1874

[3]

[Anonymous], 2000, NIH Consens Statement, V17, P1

[4]

[Anonymous], 1996, Lancet, V348, P1189

[5]

[Anonymous], 1988, NEW ENGL J MED, V319, P1681

[6]

[Anonymous], 1993, Lancet, V341, P1293

[7]

[Anonymous], 1992, Lancet, V339, P1

[8]

Beatson GT., 1896, LANCET, V148, P104, DOI DOI 10.1016/S0140-6736(01)72307-0

[9]

Bilimoria MM, 1996, SEMIN SURG ONCOL, V12, P339

[10] Ovarian function in premenopausal women treated with adjuvant chemotherapy for breast cancer [J].

Bines, J ;

Oleske, DM ;

Cobleigh, MA .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (05) :1718-1729

← 1 2 3 4 5 →